Skip to main content
Clinical Trials/NCT04737499
NCT04737499
Completed
Not Applicable

Implementation and Evaluation of A Culturally Tailored Diabetes Self-Management Program for Chinese Americans

Claremont Graduate University1 site in 1 country14 target enrollmentJuly 5, 2016
ConditionsType 2 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Claremont Graduate University
Enrollment
14
Locations
1
Primary Endpoint
Change of Concentration of HbA1c
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The project aimed to evaluate the implementation process and efficacy of a culturally tailored Diabetes Self-Management and Education (DSME) program with mobile health (mHealth) technology integration, entitled Culturally Appropriate Strategies for Chinese Americans with Diabetes (CASCADe), among Chinese American adults with Type 2 diabetes.

Detailed Description

The CASCADe program includes 1) a home visit for training of monitoring devices use, WeChat app and acquiring family support, 2) 8 weekly education sessions with a combined format of group class, games, food demonstration, group exercise, video and discussion, 3) WeChat follow-up on education tips, monitoring data summary, and group discussion. The monitoring system used a smartphone to coordinate cloud data transmission from a set of wireless devices to capture daily monitoring data on physical activity, body weight, blood pressure and blood glucose levels. WeChat app was used to facilitate behavioral self-monitoring by providing daily messages related to diabetes education curriculum, weekly summary reports on monitoring data as well as reinforcement messages and group discussion on readings and monitoring results implication. A single group pre-post-test design was adopted to evaluate changes of primary (HbA1c) and secondary (Self-efficacy, quality of life and stress coping) outcomes assessed at pre and post of intervention. Engagement and adherence in education sessions and self-monitoring system, and satisfaction with the content and delivery of intervention were also evaluated at the end of the study.

Registry
clinicaltrials.gov
Start Date
July 5, 2016
End Date
March 20, 2018
Last Updated
5 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • have been diagnosed with Type 2 diabetes
  • having been managing diabetes with diet, oral hypoglycemic agents or insulin, or both
  • confirmed HbA1c level \>=6.5% and \<10%
  • 21-75 years old
  • residents of San Gabriel Valley
  • speak and understand of Mandarin
  • willing to use the smartphone-based monitoring devices provided by the project.

Exclusion Criteria

  • unable or unwilling to give informed consent
  • plan to move out of the area within the 1-year participation study period
  • are or plan to be pregnant or breastfeeding in the next 12 months
  • have a condition that inhibits movement (e.g., unable to walk unaided, or cannot walk 1/4 mile without stopping)
  • have major physical disability or condition that prevents them from participating in person.

Outcomes

Primary Outcomes

Change of Concentration of HbA1c

Time Frame: Change from baseline HbA1c at 3 months

HbA1c was assessed using the testing kit of A1C Now+ with a finger prick of blood by trained data collector.

Secondary Outcomes

  • Change of Score of Self-efficacy(Change from baseline Self-efficacy score at 3 months)
  • Change of Score of Quality of life(Change from baseline Quality of life score at 3 months)

Study Sites (1)

Loading locations...

Similar Trials